Fred Hassan's Net Worth
-$9.07 Million
Who is Fred Hassan?
Fred Hassan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AMGEN INC, Merck & Co., Inc., Valeant Pharmaceuticals International, Inc., Prometheus Biosciences, Inc., PRECIGEN, INC., BridgeBio Pharma, Inc., Cocrystal Pharma, Inc., TIME WARNER LLC, AVON PRODUCTS INC, and ELECTRONIC DATA SYSTEMS CORP /DE/.
SEC CIK
Fred Hassan's CIK is 0001110744
Past Insider Trading and Trends
2003 was Fred Hassan's most active year for acquiring shares with 22 total transactions. Fred Hassan's most active month to acquire stocks was the month of April. 2009 was Fred Hassan's most active year for disposing of shares, totalling 11 transactions. Fred Hassan's most active month to dispose stocks was the month of May. 2013 saw Fred Hassan paying a total of $5,049,459.00 for 60,685 shares, this is the most they've acquired in one year. In 2009 Fred Hassan cashed out on 8,409,161.57 shares for a total of $2,196,990.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AMGEN INC (AMGN) Snapshot price: $298.125
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.14% | 846 |
—
|
—
| 9.19K |
May 5
| |||
Form 4
| +15.61% | 1.13K |
—
|
—
| 8.35K |
May 3
| |||
Form 4
| +18.50% | 1.13K |
—
|
—
| 7.22K |
Apr 27
| |||
Form 4
| +25.30% | 1.23K |
—
|
—
| 6.09K |
May 1
| |||
Form 4
| +35.71% | 1.28K |
—
|
—
| 4.86K |
May 3
| |||
Form 4
| +526.22% | 3.01K |
$166.63 | $501,562.10 | 3.58K |
Aug 19
| |||
Form 4
|
∞
| 572 |
—
|
—
| 572 |
Aug 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Merck & Co., Inc. (MRK) Snapshot price: $127.56
Chairman and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -935.40K |
—
|
—
|
0
|
Nov 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| +12.96% | 107.3K |
$23.70 | -$2,196,990.00 | 935.4K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| +14.89% | 107.3K |
$18.64 | -$1,727,928.00 | 828.1K |
Apr 25
| |||
Form 4
| +18.01% | 110K |
$18.26 | $2,008,773.70 | 720.8K |
Apr 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| +21.31% | 107.3K |
$21.93 | -$2,032,911.00 | 610.8K |
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4/A
| +151.75% | 303.5K |
$15.42 | $4,679,170.00 | 503.5K |
Nov 26
| |||
Form 4
| +151.75% | 303.5K |
$15.42 | $4,679,170.00 | 503.5K |
Nov 26
| |||
| No matching records found | |||||||||
Valeant Pharmaceuticals International, Inc. (BHC) Snapshot price: $8.13
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1,717.75% | 51K |
$99.01 | $5,049,459.00 | 53.97K |
Aug 29
| |||
Form 4
|
∞
| 2.97K |
—
|
—
| 2.97K |
Aug 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Prometheus Biosciences, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.12K |
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
∞
| 2.12K |
—
|
—
| 2.12K |
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PRECIGEN, INC. (PGEN) Snapshot price: $1.42
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.47% | 44.05K |
$1.43 | $62,998.65 | 1.03M |
Mar 14
| |||
Form 4
| +12.16% | 106.84K |
—
|
—
| 985.78K |
Mar 9
| |||
Form 4
| +184.82% | 570.35K |
$1.75 | $998,103.75 | 878.94K |
Aug 14
| |||
Form 4
| +18.55% | 48.29K |
$1.17 | $56,499.30 | 308.6K |
Mar 9
| |||
Form 4
| +30.98% | 61.58K |
—
|
—
| 260.31K |
Feb 22
| |||
Form 4
| +8.88% | 16.21K |
—
|
—
| 198.73K |
Mar 25
| |||
Form 4
| +17.99% | 27.83K |
$2.03 | $56,498.96 | 182.52K |
Feb 22
| |||
Form 4
| +4.97% | 7.33K |
$7.71 | $56,498.88 | 154.69K |
Mar 25
| |||
Form 4
| +73.02% | 62.19K |
—
|
—
| 147.36K |
Mar 13
| |||
Form 4
| +49.26% | 28.11K |
$2.01 | $56,499.09 | 85.17K |
Mar 13
| |||
Form 4
| +76.34% | 24.7K |
—
|
—
| 57.06K |
Mar 8
| |||
Form 4
| +32.36% | 7.91K |
—
|
—
| 32.36K |
Mar 23
| |||
Form 4
| +84.07% | 11.17K |
$5.06 | $56,499.96 | 24.45K |
Mar 8
| |||
Form 4
| +36.83% | 3.58K |
$15.80 | $56,485.00 | 13.28K |
Mar 23
| |||
Form 4
| +40.67% | 2.81K |
—
|
—
| 9.71K |
Mar 16
| |||
Form 4
|
∞
| 6.9K |
$29.02 | $200,266.29 | 6.9K |
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||